Angiotensin-converting enzyme inhibitors (ACEIs), commonly used in CHF treatment, interestingly, not only improve cardiac function but also suppress inflammatory responses and improve mitochondrial function, thereby reducing muscle catabolism [47]. Here, ACE is linked to congestive heart failure.